Cargando…

New insights into natural products that target the gut microbiota: Effects on the prevention and treatment of colorectal cancer

Colorectal cancer (CRC) is one of the most common malignant carcinomas. CRC is characterized by asymptomatic onset, and most patients are already in the middle and advanced stages of disease when they are diagnosed. Inflammatory bowel disease (IBD) and the inflammatory-cancer transformation of advan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Lu, Dong, Jiahuan, Liu, Yujing, Qian, Yufan, Zhang, Guangtao, Zhou, Wenjun, Zhao, Aiguang, Ji, Guang, Xu, Hanchen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420899/ https://www.ncbi.nlm.nih.gov/pubmed/36046819 http://dx.doi.org/10.3389/fphar.2022.964793

Ejemplares similares

Can Natural Products be Used to Overcome the Limitations of Colorectal Cancer Immunotherapy?
por: Dong, Jiahuan, et al.
Publicado: (2022)

Acacetin exerts antitumor effects on gastric cancer by targeting EGFR
por: Zhang, Guangtao, et al.
Publicado: (2023)

The Pathogenesis of HCC Driven by NASH and the Preventive and Therapeutic Effects of Natural Products
por: Shao, Gaoxuan, et al.
Publicado: (2022)

Sijunzi decoction granules in the prevention and treatment of recurrence of colorectal adenoma: Study protocol for a multicenter, randomized, double-blind, placebo-controlled trial
por: Ni, Wenjing, et al.
Publicado: (2023)

The circRNA expression profile of colorectal inflammatory cancer transformation revealed potential predictive biomarkers
por: Lu, Lu, et al.
Publicado: (2022)

Microbiota and Colorectal Cancer: From Gut to Bedside
por: Silva, Miguel, et al.
Publicado: (2021)

Berberine Alleviates Non-alcoholic Steatohepatitis Through Modulating Gut Microbiota Mediated Intestinal FXR Activation
por: Shu, Xiangbing, et al.
Publicado: (2021)

Gut Microbiota and Related Metabolites Were Disturbed in Ulcerative Colitis and Partly Restored After Mesalamine Treatment
por: Dai, Liang, et al.
Publicado: (2021)

Naturally Occurring TPE-CA Maintains Gut Microbiota and Bile Acids Homeostasis via FXR Signaling Modulation of the Liver–Gut Axis
por: Liu, Linlin, et al.
Publicado: (2020)

Secondary Bile Acids and Tumorigenesis in Colorectal Cancer
por: Liu, Yujing, et al.
Publicado: (2022)

The role of gut microbiota and drug interactions in the development of colorectal cancer
por: Wu, Jinna, et al.
Publicado: (2023)

Changes in the Gut Microbiota May Affect the Clinical Efficacy of Oral Anticoagulants
por: Chen, Wenjun, et al.
Publicado: (2022)

Targeting gut microbiota and immune crosstalk: potential mechanisms of natural products in the treatment of atherosclerosis
por: Jing, Jinpeng, et al.
Publicado: (2023)

Disordered Gut Microbiota in Colorectal Tumor-Bearing Mice Altered Serum Metabolome Related to Fufangchangtai
por: Cai, Mengmeng, et al.
Publicado: (2022)

Naoxintong Capsule Alternates Gut Microbiota and Prevents Hyperlipidemia in High-Fat-Diet Fed Rats
por: Lu, Yihang, et al.
Publicado: (2022)

The Role of Gut Microbiota—Gut—Brain Axis in Perioperative Neurocognitive Dysfunction
por: Lu, Jian, et al.
Publicado: (2022)

Sini Decoction Ameliorates Colorectal Cancer and Modulates the Composition of Gut Microbiota in Mice
por: Wang, Yishan, et al.
Publicado: (2021)

Understanding the Gut-Kidney Axis in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: An Analysis of Gut Microbiota Composition
por: Yu, Meilian, et al.
Publicado: (2022)

The Role of Gut Microbiota and Microbiota-Related Serum Metabolites in the Progression of Diabetic Kidney Disease
por: Zhang, Qing, et al.
Publicado: (2021)

Natural products from plants and microorganisms: Novel therapeutics for chronic kidney disease via gut microbiota regulation
por: Zheng, Lin, et al.
Publicado: (2023)

Advances in natural compound-based nanomedicine and the interaction with gut microbiota in ulcerative colitis therapy
por: Zhang, Jinlan, et al.
Publicado: (2023)

The role of the gut microbiota and probiotics associated with microbial metabolisms in cancer prevention and therapy
por: Wang, Zijun, et al.
Publicado: (2022)

METTL3 promotes colorectal carcinoma progression by regulating the m6A–CRB3–Hippo axis
por: Pan, Jiashu, et al.
Publicado: (2022)

Research Status and Hotspots of Anticancer Natural Products Based on the Patent Literature and Scientific Articles
por: Shen, Junkai, et al.
Publicado: (2022)

Effective Regulation of Gut Microbiota With Probiotics and Prebiotics May Prevent or Alleviate COVID-19 Through the Gut-Lung Axis
por: Xu, Lei, et al.
Publicado: (2022)

A Review of the Effects of Natural Compounds, Medicinal Plants, and Mushrooms on the Gut Microbiota in Colitis and Cancer
por: Cheung, Man Kit, et al.
Publicado: (2020)

NSAID–Gut Microbiota Interactions
por: Maseda, Damian, et al.
Publicado: (2020)

Prevention of Wogonin on Colorectal Cancer Tumorigenesis by Regulating p53 Nuclear Translocation
por: Feng, Qian, et al.
Publicado: (2018)

New Insights toward Colorectal Cancer Chemotherapy Using Natural Bioactive Compounds
por: Redondo-Blanco, Saúl, et al.
Publicado: (2017)

Regional Differences in the Gut Microbiota and Gut-Associated Immunologic Factors in the Ileum and Cecum of Rats With Collagen-Induced Arthritis
por: Xu, Huihui, et al.
Publicado: (2020)

FHL1 Inhibits the Progression of Colorectal Cancer by Regulating the Wnt/β-Catenin Signaling Pathway
por: Liu, Yujing, et al.
Publicado: (2021)

Bone Health and Natural Products- An Insight
por: Suvarna, Vasanti, et al.
Publicado: (2018)

Chocolate, gut microbiota, and human health
por: Hayek, Nabil
Publicado: (2013)

The Role of Gut Microbiota in Atherosclerosis and Hypertension
por: Ma, Junli, et al.
Publicado: (2018)

The gut-lung axis: Gut microbiota changes associated with pulmonary fibrosis in mouse models induced by bleomycin
por: Quan, Yunyun, et al.
Publicado: (2022)

Gut fungi differentially response to the antipyretic (heat-clearing) and diaphoretic (exterior-releasing) traditional Chinese medicines in Coptis chinensis-conditioned gut microbiota
por: Yang, Yanan, et al.
Publicado: (2022)

Potential benefits of metformin and pioglitazone combination therapy via gut microbiota and metabolites in high-fat diet-fed mice
por: Wang, Dongmei, et al.
Publicado: (2022)

Can proline dehydrogenase—a key enzyme involved in proline metabolism—be a novel target for cancer therapy?
por: Xu, Xiangyuan, et al.
Publicado: (2023)

Resveratrol Modulates the Gut Microbiota and Inflammation to Protect Against Diabetic Nephropathy in Mice
por: Cai, Ting-Ting, et al.
Publicado: (2020)

Glabridin Prevents Doxorubicin-Induced Cardiotoxicity Through Gut Microbiota Modulation and Colonic Macrophage Polarization in Mice
por: Huang, Keqing, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5mkvsoro25rrogb5e0g2a35lts